Esteban-Lopez, Maria
Wilson, Kenneth J.
Myhr, Courtney
Kaftanovskaya, Elena M.
Henderson, Mark J.
Southall, Noel T. http://orcid.org/0000-0003-4500-880X
Xu, Xin
Wang, Amy
Hu, Xin
Barnaeva, Elena
Ye, Wenjuan
George, Emmett R.
Sherrill, John T. http://orcid.org/0000-0003-3998-5364
Ferrer, Marc
Morello, Roy
Agoulnik, Irina U. http://orcid.org/0000-0003-4889-0324
Marugan, Juan J. http://orcid.org/0000-0002-3951-7061
Agoulnik, Alexander I. http://orcid.org/0000-0001-6587-6845
Funding for this research was provided by:
Doctoral Evidence Acquisition Fellowship (DEA) and Dissertation Year Fellowship (DYF) from the University Graduate School at Florida International University.
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20 GM125503)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070093, R01AR070093)
National Center for Advancing Translational Sciences Intramural Research Program
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Article History
Received: 3 May 2022
Accepted: 20 October 2022
First Online: 4 November 2022
Competing interests
: M.E.-L., K.J.W., C.M., M.J.H., N.T.S., X.H., E.B., W.Y., M.F., I.U.A., J.J.M., A.I.A. are the inventors in patent application No. 63/308,768, assigned to NIH, DHHS, and FIU, entitled “Small Molecule Agonists of the Insulin-like (INSL3) Peptide Receptor RXFP2 and Methods of Use Thereof”, relating to the discovery and the use of small molecule agonists of RXFP2. The remaining authors declare no competing interests.